\-\ Texto\\:\\ \ \(0\)\
\-\ asymptomatic\ \(399\)\
\-\ neurosurgical\\ consult\\ to\\ evaluate\\ for\\ excision\ \(0\)\
\-\ mr\ \(14\)\
\-\ 3\\.5\\ cm\\ extra\\-axial\\,\\ middle\\ cranial\\ fossa\\ mass\\ with\\ layering\\ material\\ and\\ signal\\ characteristics\\ consistent\\ with\\ lipid\\.\\ \\ dependent\\,\\ non\\-enhancing\\ debris\\ is\\ seen\\ more\\ inferiorly\\ with\\ signal\\ characteristics\\ consistent\\ with\\ blood\\ or\\ proteinaceous\\ material\\.\\ \\ there\\ is\\ no\\ restricted\\ diffusion\\.\\ \\ mass\\ effect\\ is\\ noted\\ at\\ the\\ right\\ anterior\\ temporal\\ tip\\ without\\ significant\\ midline\\ shift\\ suggestive\\ of\\ a\\ chronic\\ evolution\\.\ \(0\)\
\-\ intracranial\\ dermoid\\ inclusion\\ cyst\ \(0\)\
\-\ \\â\\€\\¢\\ dermoid\\ inclusion\\ cyst\ \(0\)\
\-\ \\â\\€\\¢\\ epidermoid\\ inclusion\\ cyst\ \(0\)\
\-\ \\â\\€\\¢\\ teratoid\\ tumor\ \(0\)\
\-\ 23\\ y\\.o\\.\\ man\\ presents\\ for\\ follow\\ up\\ evaluation\\ of\\ an\\ asymptomatic\\ mass\\ originally\\ diagnosed\\ as\\ intracranial\\ lipoma\\ as\\ a\\ child\\.\ \(1\)\
\-\ the\\ patient\\ was\\ asymptomatic\\ but\\ consulted\\ to\\ neurosurgery\\ for\\ evaluation\\ for\\ excision\\ due\\ to\\ the\\ potential\\ risk\\ of\\ rupture\\ possibly\\ causing\\ chemical\\ meningitis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ inclusion\\:\\ 0\\.11954932641993374\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.06564982722718381\ \(0\)\
\-\ characteristics\\:\\ 0\\.06441167018937367\ \(0\)\
\-\ dermoid\\:\\ 0\\.05902329542633899\ \(0\)\
\-\ material\\:\\ 0\\.057853123487914895\ \(0\)\
\-\ intracranial\\:\\ 0\\.054719874801359134\ \(0\)\
\-\ teratoid\\:\\ 0\\.05321029511165487\ \(0\)\
\-\ excision\\:\\ 0\\.05314016252371657\ \(0\)\
\-\ cyst\\:\\ 0\\.05219025309150233\ \(0\)\
\-\ proteinaceous\\:\\ 0\\.04626869865806279\ \(0\)\
\-\ lipid\\:\\ 0\\.04408928901827657\ \(0\)\
\-\ evolution\\:\\ 0\\.04371966656244754\ \(0\)\
\-\ neurosurgical\\:\\ 0\\.04303048642452537\ \(0\)\
\-\ layering\\:\\ 0\\.04101758365382078\ \(0\)\
\-\ chemical\\:\\ 0\\.03984977547331125\ \(0\)\
\-\ non\\-enhancing\\:\\ 0\\.03942879175244147\ \(0\)\
\-\ debris\\:\\ 0\\.03942879175244147\ \(0\)\
\-\ consulted\\:\\ 0\\.03942879175244147\ \(0\)\
\-\ consult\\:\\ 0\\.03846855155820553\ \(0\)\
\-\ 3\\.5\\:\\ 0\\.037779371420283356\ \(0\)\
\-\ evaluation\\:\\ 0\\.037609678724648606\ \(0\)\
\-\ originally\\:\\ 0\\.03656465437425927\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.036425645747985055\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.03561396253627018\ \(0\)\
\-\ dependent\\:\\ 0\\.03493049851951161\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.03449120111306957\ \(0\)\
\-\ signal\\:\\ 0\\.03413748985261786\ \(0\)\
\-\ inferiorly\\:\\ 0\\.0339756445733346\ \(0\)\
\-\ meningitis\\:\\ 0\\.03358705900979255\ \(0\)\
\-\ tip\\:\\ 0\\.03321743655396352\ \(0\)\
\-\ possibly\\:\\ 0\\.03312778157178926\ \(0\)\
\-\ consistent\\:\\ 0\\.031746943467139445\ \(0\)\
\-\ potential\\:\\ 0\\.031174530743743045\ \(0\)\
\-\ epidermoid\\:\\ 0\\.030837774966691274\ \(0\)\
\-\ 23\\:\\ 0\\.03077218358227374\ \(0\)\
\-\ shift\\:\\ 0\\.030707155220975318\ \(0\)\
\-\ lipoma\\:\\ 0\\.03026694589667774\ \(0\)\
\-\ restricted\\:\\ 0\\.029793306828637327\ \(0\)\
\-\ diffusion\\:\\ 0\\.028977923008998197\ \(0\)\
\-\ child\\:\\ 0\\.02833594400555054\ \(0\)\
\-\ cranial\\:\\ 0\\.028148878758653784\ \(0\)\
\-\ causing\\:\\ 0\\.02796632154972151\ \(0\)\
\-\ suggestive\\:\\ 0\\.027657064015477153\ \(0\)\
\-\ rupture\\:\\ 0\\.027485853167619267\ \(0\)\
\-\ mass\\:\\ 0\\.027010477430626467\ \(0\)\
\-\ fossa\\:\\ 0\\.026384845687129767\ \(0\)\
\-\ evaluate\\:\\ 0\\.026168380744371764\ \(0\)\
\-\ temporal\\:\\ 0\\.02592341573950104\ \(0\)\
\-\ midline\\:\\ 0\\.025046440055594855\ \(0\)\
\-\ diagnosed\\:\\ 0\\.023804508763598527\ \(0\)\
\-\ middle\\:\\ 0\\.023675446739715438\ \(0\)\
\-\ risk\\:\\ 0\\.023448535207265808\ \(0\)\
\-\ effect\\:\\ 0\\.02292089585658519\ \(0\)\
\-\ for\\:\\ 0\\.02209418632250652\ \(0\)\
\-\ mr\\:\\ 0\\.02056969296929117\ \(0\)\
\-\ follow\\:\\ 0\\.02056969296929117\ \(0\)\
\-\ as\\:\\ 0\\.019584507665062544\ \(0\)\
\-\ y\\.o\\:\\ 0\\.018684692671111364\ \(0\)\
\-\ chronic\\:\\ 0\\.01823476994626515\ \(0\)\
\-\ blood\\:\\ 0\\.017669780852343178\ \(0\)\
\-\ significant\\:\\ 0\\.017407932962531996\ \(0\)\
\-\ up\\:\\ 0\\.017407932962531996\ \(0\)\
\-\ cm\\:\\ 0\\.017363303922855955\ \(0\)\
\-\ due\\:\\ 0\\.017274826916309393\ \(0\)\
\-\ anterior\\:\\ 0\\.016672672907293466\ \(0\)\
\-\ more\\:\\ 0\\.01619072961600126\ \(0\)\
\-\ noted\\:\\ 0\\.01534409991251965\ \(0\)\
\-\ man\\:\\ 0\\.015310089720378782\ \(0\)\
\-\ without\\:\\ 0\\.01524252398756182\ \(0\)\
\-\ tumor\\:\\ 0\\.015092668951597055\ \(0\)\
\-\ \\-\\:\\ 0\\.013876730747790634\ \(0\)\
\-\ but\\:\\ 0\\.013806843189648014\ \(0\)\
\-\ presents\\:\\ 0\\.013224577996272167\ \(0\)\
\-\ seen\\:\\ 0\\.012792633447482502\ \(0\)\
\-\ is\\:\\ 0\\.012779335872380128\ \(0\)\
\-\ to\\:\\ 0\\.009706093373704233\ \(0\)\
\-\ there\\:\\ 0\\.0096342087610984\ \(0\)\
\-\ an\\:\\ 0\\.00895200654761159\ \(0\)\
\-\ at\\:\\ 0\\.00877093297599722\ \(0\)\
\-\ or\\:\\ 0\\.00758729355275536\ \(0\)\
\-\ was\\:\\ 0\\.0074869509258612636\ \(0\)\
\-\ right\\:\\ 0\\.00683054325083649\ \(0\)\
\-\ no\\:\\ 0\\.006518516293210621\ \(0\)\
\-\ patient\\:\\ 0\\.006489332809972636\ \(0\)\
\-\ a\\:\\ 0\\.006009087906342444\ \(0\)\
\-\ \\,\\:\\ 0\\.0041016676593528395\ \(0\)\
\-\ with\\:\\ 0\\.0035455810936330222\ \(0\)\
\-\ the\\:\\ 0\\.0031420291978096772\ \(0\)\
\-\ of\\:\\ 0\\.002647813654499737\ \(0\)\
\-\ \\.\\:\\ 0\\.001882551156677454\ \(0\)\
\-\ and\\:\\ 0\\.0013637045888804428\ \(0\)\
